SCHEMBL9905069

SCHEMBL9905069

CC(C)(C)c1ccc(O)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 1/20 0.50
GALR3 O60755 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 4/20 0.47
ALOX15 P16050 2/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
CYP2C9 P11712 1/20 0.47
MIF P14174 1/20 0.47
TYR P14679 1/20 0.47
NFE2L2 Q16236 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GPR35 Q9HC97 5/20 0.46
TSHR P16473 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
CHEK1 O14757 1/20 0.43
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL7150776 0.82 KIF11 (0.46) HTTSMN1; SMN2ALDH1A1ALOX15LMNA
SCHEMBL7327413 0.81 KIF11 (0.48) HTTSMN1; SMN2ALDH1A1ALOX15LMNA
SCHEMBL30619356 0.81 KIF11 (0.48) HTTSMN1; SMN2ALDH1A1ALOX15LMNA
SCHEMBL13945797 0.79 ALDH1A1 (0.50) HTTSMN1; SMN2MEN1GALR3KMT2A
SCHEMBL31634157 0.79 ALDH1A1 (0.58) HTTSMN1; SMN2MEN1GALR3KMT2A
SCHEMBL12737451 0.79 TSHR (0.62) HTTSMN1; SMN2MEN1GALR3KMT2A
SCHEMBL446475 0.79 TDP1 (0.55) HTTSMN1; SMN2MEN1GALR3KMT2A
SCHEMBL16960436 0.79 CHEK1 (0.47) HTTSMN1; SMN2MEN1GALR3KMT2A
SCHEMBL15356395 0.78 TDP1 (0.53) HTTSMN1; SMN2MEN1GALR3KMT2A
SCHEMBL16955053 0.78 MEN1 (0.42) HTTSMN1; SMN2MEN1GALR3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752510-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM Vertex Pharmaceuticals Incorporated (US) 2020-12-23 EP disclosed
WO-2019161078-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-08-22 WO disclosed
WO-2011072241-A9 4-OXO-1H-QUINOLINE-3-CARBOXAMIDES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-14 WO disclosed